Acute intermittent porphyria: a test of clinical acumen.
Rashmi DhitalSijan BasnetDilli Ram PoudelKhema Raj BhusalPublished in: Journal of community hospital internal medicine perspectives (2017)
Acute intermittent porphyria (AIP) is a rare autosomal dominant hepatic porphyria due to deficiency of hydroxymethylbilane synthase (HMBS), also known as porphobilinogen deaminase leading to accumulation of porphyrin precursors. However, gene defect alone is usually not sufficient to cause an acute attack, and many extrinsic factors play a role. Diagnostic tests are defined, but clinical suspicion is often delayed as symptoms mimic other common conditions. We report a case of a 18-year-old male with severe, persistent, and generalized abdominal pain along with marked hyponatremia, with subsequent development of altered mentation needing intensive care. He improved after infusion of intravenous dextrose. AIP can mimic many common surgical and medical conditions such as appendicitis, cholecystitis, pancreatitis, etc., and may lead to extensive diagnostics or surgical intervention if missed. Diagnosis of AIP requires high clinical suspicion. It should be considered in a patient with recurrent abdominal symptoms, intractable hyponatremia, along with neurological manifestations. Early diagnosis and treatment can prevent recurrent episodes and can potentially be lifesaving. Abbreviations: AIP: Acute intermittent porphyria; ALA: Aminolevulinic acid; PBG: Porphobilinogen.
Keyphrases
- liver failure
- respiratory failure
- drug induced
- aortic dissection
- photodynamic therapy
- high intensity
- randomized controlled trial
- abdominal pain
- healthcare
- gene expression
- low dose
- intensive care unit
- heart failure
- early onset
- extracorporeal membrane oxygenation
- case report
- copy number
- sleep quality
- depressive symptoms
- blood brain barrier
- quantum dots